TCL Archive Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research January 22, 1982
TCL Archive Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990 January 27, 1989
TCL Archive NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. March 12, 2010
